wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q51749083-2CC2461F-11EC-409D-BABF-05F9F6477ECF
Q51749083-2CC2461F-11EC-409D-BABF-05F9F6477ECF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51749083-2CC2461F-11EC-409D-BABF-05F9F6477ECF
Targeting the proliferative and chemoresistant compartment in chronic lymphocytic leukemia by inhibiting survivin protein.
P2860
Q51749083-2CC2461F-11EC-409D-BABF-05F9F6477ECF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51749083-2CC2461F-11EC-409D-BABF-05F9F6477ECF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5054f54179749b3ccfb3e21756c5924a82bd2aba
P2860
A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer.